Navigation Links


Nervous in Medical Technology

Gene Findings Unlocking Reasons for Neuroblastoma Risk

... cancer. Originating in the peripheral nervous system, neuroblastoma is the most common solid ... by which BARD1 gene variants act on developing nervous system cells to give rise to cancer during fetal ... genes that are involved in the development of the nervous system, and the CNV they discovered changes how ...

Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults

... the modulation of sodium channel activity in the nervous system. Sodium channels play a crucial role in regulating the activity of the nervous system to help nerve cells communicate. Sometimes ... medicines with a focus on the fields of central nervous system and immunology disorders. Employing ....

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... that the transplanted cells integrated into the nervous system of the host. The rats had a genetic ... that they can become an integral part of the rat nervous system that controls the muscles. I would expect ... readily accepted by and integrated into a human nervous system, such as in an ALS or a spinal cord injury ...

New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures

... patients taking Keppra XR experienced fewer nervous system side effects than those taking the same ... lower rates of adverse events related to nervous system disorders (i.e., headache, somnolence and ... medicines with a focus on the fields of central nervous system and immunology disorders. Employing ...

Protein Shown to Play a Key Role in Normal Development of Nervous System

... plays a key role in controlling the developing nervous system. Research into how that protein helps ... for patients who suffer injuries to their nervous system, including spinal cord injury. "This expands our basic knowledge of how the nervous system develops in animals and humans," said ...

Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)

... on the treatment of obesity and other central nervous system-related disorders, today presented data ... on the treatment of obesity and other central nervous system-related disorders. The Company's lead ... act on a specific group of neurons in the central nervous system with the goal of achieving appetite ...

Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule

... Drug Administration (FDA) to treat other central nervous system disorders. Orexigen has developed ... product candidates for the treatment of central nervous system disorders, including obesity. The ... other proprietary drugs for use in other central nervous system disorders. Further information about the ...

Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimer's Disease

... pipeline of product candidates in central nervous system disorders," said Paul E. Freiman, ... Technologies and Buck focused on central nervous system conditions. "With these resources and ... novel, first-in-class agents for central nervous system conditions and other serious unmet medical ...

European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection

... Fifty-three percent of patients reported central nervous system symptoms (including dizziness [28.1%], ... 4 weeks of therapy, the prevalence of nervous system symptoms of at least moderate severity ... treated with regimens containing efavirenz. nervous system symptoms are not predictive of the less ...

Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe

... Fifty-three percent of patients reported central nervous system symptoms (including dizziness [28.1%], ... After 4 weeks of therapy, the prevalence of nervous system symptoms of at least moderate severity ... treated with regimens containing efavirenz. nervous system symptoms are not predictive of the less ...

European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

... Fifty-three percent of patients reported central nervous system symptoms (including dizziness [28.1%], ... 4 weeks of therapy, the prevalence of nervous system symptoms of at least moderate severity ... treated with regimens containing efavirenz. nervous system symptoms are not predictive of the less ...

Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord

... leads to stroke or death. Primary central nervous system vasculitis (PCNSV) can best be identified ... of the Mayo Clinic Research Primary central nervous system vasculitis has two traits that make ... -- The annual incidence rate of primary central nervous system vasculitis was 2.4 cases per 1 million ...

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV

... Fifty-three percent of patients reported central nervous system symptoms (including dizziness [28.1%], ... 4 weeks of therapy, the prevalence of nervous system symptoms of at least moderate severity ... treated with regimens containing efavirenz. nervous system symptoms are not predictive of the less ...

Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain

... projects are focused upon peripheral and central nervous system applications. To that end, Diamyd seeks to ... that NTDDS proposes a new and broad class of nervous system disease therapies. Pain is transmitted ... the synapse between the peripheral and central nervous systems. This synapse provides input from the ...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... a chronic, progressive, often disabling disease that attacks the central nervous system(ii). MS is caused by damage to myelin, the protective sheath surrounding nerve fibers in the central nervous system, resulting in disrupted nerve impulses traveling to and from the ...

Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression

... technology to identify novel pathways for the treatment of central nervous system (CNS) diseases, announced today results from the first clinical ... novel pathways for small molecule therapeutics to treat various central nervous system (CNS) diseases. Neurogenesis is the process by which endogenous ...

Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder

... of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune ... Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. The company's proprietary ...

Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints

... 0.5% - 5% of adults worldwide. Fibromyalgia is believed to be a central nervous system condition, resulting from neurological changes in how the brain ... and commercialization of innovative medicines with a focus on central nervous system and immunology disorders. Employing around 10,000 people in over 40 ...

ADHD Genes Found; Known to Play Roles in Neurodevelopment

... the gene alterations we found are involved in the development of the nervous system, they may eventually guide researchers to better targets in ... functions such as learning, behavior, synaptic transmission and nervous system development. "We took a systems biology approach, grouping ...

Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia

... of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune ... Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. The company's proprietary ...

CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders

... and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced that it has obtained the rights to develop ... and commercializing innovative treatments for diseases of the central nervous system. CeNeRx's most advanced compound, a reversible inhibitor of ...

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

... in peripheral tissues such as liver and fat without affecting the central nervous system, further validating Isis' anti-obesity therapeutic strategy. ... have significant therapeutic utility without the potential for central nervous system toxicities that plague many centrally acting anti-obesity drugs," ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... B virus (HBV) infection or think you may be a carrier of HBV. nervous system disorders (like multiple sclerosis or Guillain-Barre syndrome). ... fever that doesn't go away, bruising, bleeding or severe paleness. nervous system disorders - numbness, weakness, tingling, changes in your vision or ...

New Therapy Enlists Immune System to Boost Cure Rate in a Childhood Cancer

... cure rates for children with neuroblastoma, a challenging cancer of the nervous system. John M. Maris, M.D., chief of Oncology at The Children's ... for pediatric cancers. Neuroblastoma, a cancer of the peripheral nervous system, usually appears as a solid tumor in the chest or abdomen. ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... of a family of novel opioid receptor compounds with the potential to treat nervous system disorders and addiction. The family of compounds was licensed to ... of diseases and medical conditions, including addiction, pain, and other nervous system disorders. Alkermes screened the library of compounds from ...

Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's Treatments

... that it has developed a robust medical imaging methodology for Central nervous System (CNS) clinical trials involving Alzheimer's disease. The method, ... services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology ...

Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications

... of diagnostic and therapeutic agents across the BBB into the central nervous system ("CNS"). The claims broadly encompass all neurological disorders, ... and therapeutic agents across the blood-brain barrier into the central nervous system; that the allowed claims and patents, if issued, offer strong IP ...

Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder

... of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune ... Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. The company's proprietary ...

Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes

... preclinical and Phase I studies--estrogen-agonist effects on the central nervous system while protecting against breast and uterine tissue stimulation," ... enables RAD1901 to function as an estrogen agonist within the central nervous system and thereby relieve hot flashes. RAD1901 was discovered by Eisai ....

Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression

... of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune ... Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology. The company's proprietary ...

ICON and MedAvante Sign Alliance Agreement

... Aims To Enhance Precision and Reduce High Failure Rates in Central nervous System Clinical Trials DUBLIN and Hamilton, N.J., March 16 ... platform that addresses a major cause of clinical trial failure in Central nervous System (CNS) development: variability in both clinical diagnosis of the ...

Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study

... is believed to potentiate the activity of these chemicals in the central nervous system (brain and spinal cord). While the mechanism of action of Cymbalta ... to increasing the activity of serotonin and norepinephrine in the central nervous system. Cymbalta is approved in the United States for the acute and ...

Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

... products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived ... pipeline of preclinical programs targeting inflammation and central nervous system disorders. For more information on Omeros, visit the Company's Web ...

New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors

... from the interface between the endocrine (hormonal) system and the nervous system, and includes carcinoid tumors and pancreatic NETs. Treatment ... in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is ...

AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia

... NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept's product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. ...

Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin

... shown to be instrumental in the baby's pre- and postnatal brain, eye and nervous system development, increase the baby's gestation period, birth weight and ... and vitamin B6. Vitamin B6 contributes to a baby's developing brain and nervous system(5) and may help some women reduce severe nausea or vomiting during ...

Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain

... is believed to potentiate the activity of these chemicals in the central nervous system (brain and spinal cord). While the exact mechanism of action of ... to increasing the activity of serotonin and norepinephrine in the central nervous system. Duloxetine is approved in the United States for the acute ...

FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

... are drugs that bind to and activate mu-opioid receptors in the central nervous system. These drugs modify sensory and affective aspects of pain, inhibit ... is perceived. Norepinephrine reuptake inhibitors are a type of central nervous system medication that increases the level of norepinephrine in the brain ...

Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia

... 0.5% - 5% of adults worldwide. Fibromyalgia is believed to be a central nervous system condition, resulting from neurological changes in how the brain ... and commercialization of innovative medicines with a focus on central nervous system and immunology disorders. Employing around 12,000 people in over 40 ...

Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus

... targets the heart, joints, skin, lungs, blood vessels, liver, kidneys and nervous system. Lupus is characterized by periods of flares, or ... of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 12,000 people in ...
Other Contentsprokaryotesprokaryotesprokaryotesprokaryotesproofproofproofproofproofproofprostaglandinsprostaglandinsprostateprostateprostateprostateprostateprostateprostatearrayarrayarrayarrayarrayarrayarrayarrayfoldingfoldingfoldingfoldingfoldingfolding
(Date:12/3/2009)... his co-workers discovered that specific types of human papillomavirus ... these pathogens cause cells to degenerate. It is known ... and E7. Both proteins switch off different cellular control ... Frank Rsl and his co-workers at DKFZ have now ...
(Date:12/3/2009)... animal species can be likened to emptying a museum of ... into the trash, or replacing every local cuisine with McDonald,s ... may not just make the world boring. New research now ... catching some nasty disease. , "Habitat destruction and biodiversity loss,"driven ...
(Date:12/3/2009)... message: , , Preliminary Press Conference Topics, ... of Sciences museum, Attention PIOs: Sending Press Releases ... deadline 10 December, News Media registration information , ... 7 December, Who,s coming, , For important ...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2Species down, disease up 2Species down, disease up 3Species down, disease up 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Doctor Pharmacist Teams Boost Blood Pressure Control 61978 1Doctor Pharmacist Teams Boost Blood Pressure Control 61978 2Doctor Pharmacist Teams Boost Blood Pressure Control 61978 3 Vioxx Problems Known Years Before Recall 61976 1 Vioxx Problems Known Years Before Recall 61976 2 Vioxx Problems Known Years Before Recall 61976 3 Vioxx Problems Known Years Before Recall 61976 4Hazelden Names Leadership Team for New Recovery Center in Naples Florida 61974 1Hazelden Names Leadership Team for New Recovery Center in Naples Florida 61974 2
(Date:12/6/2009)... oysters harvested from San Antonio Bay ,, SILVER ... and Drug Administration is advising consumers to avoid eating ... after Nov. 16 due to reports of norovirus-associated illnesses ... this area, which is located on the Gulf of ... ,, The FDA, along with the Centers for Disease ...
(Date:12/6/2009)... signs of feline DNA in virus , , SUNDAY, Dec. 6 ... AIDS might be found in a tiger that lived thousands ... It appears the virus took on a bit of a ... cat remains in the virus to this day. That tiger, ... evolution of the virus that ultimately led to its infection ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Blood clotting, or ... bleeding when a blood vessel is injured. Sometimes, ... without an obvious injury or do not dissolve ... presented today at the 51st Annual Meeting of ... practice of using the anticoagulants aspirin and heparin ...
(Date:12/6/2009)... Belluck & Fox, LLP says dangerous substances such as asbestos have ... ... New York, NY (PRWEB) December 6, 2009 -- As parents ... alert to reports of recalls due to lead paint or asbestos ... 230,000 children visit hospital emergency rooms each year due to toy-related ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
Breaking Medicine News(10 mins):Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:AIDS May Date Back to Ancient Tiger 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3
Other TagsBravoEstroneMicroalbuminMyoglobinTroponinUltrasensitiveIntactCalcitoninTibialPivotOther Tagschicken 2chicken 3chicken 4chicken 5chicken 6chicken 7chicken 8chicken 9chicken 10from 2from 3from 4from 5from 6from 7from 8from 9from 10saving 2saving 3saving 4saving 5saving 6saving 7saving 8saving 9saving 10life 2life 3life 4life 5life 6life 7life 8life 9life 10death 2death 3death 4death 5death 6death 7death 8death 9death 10count 2count 3count 4count 5count 6count 7count 8count 9hearing 2hearing 3hearing 4helping 2helping 3helping 4helping 5helping 6helping 7helping 8helping 9helping 10explore 2explore 3explore 4explore 5explore 6explore 7explore 8explore 9explore 10station 2